// App-Quantinova.ai

PB1111 : A novel prothrombin R533Q variant in patient with recurrent venous thrombosis

Researchers

Presenter

  • C. Van Laer

Principal Investigators

  • K. Freson

  • V. Muczynski

  • K. Peerlinck

  • C. Thys

  • M. Jacquemin

Medical Centers

  • Center for Molecular and Vascular Biology, University of Leuven; Clinical Department of Laboratory Medicine, University Hospitals Leuven, Belgium, Leuven, Vlaams-Brabant, Belgium

  • Center for Molecular and Vascular Biology, KULeuven, University Hospitals Leuven, Leuven, Vlaams-Brabant, Belgium

  • Research Department of Haematology, University College London (UCL) – Cancer Institute, London, United-Kingdom, London, England, United Kingdom

  • University Hospitals Leuven, Leuven, Vlaams Brabant, Belgium

  • KU Leuven, Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, Leuven, Belgium

Locations

  • Belgium

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Pulmonary embolism

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved